SUBMIT BOOK PROPOSAL
Online Store
benthambooks logo

Site Breadcrumb

Frontiers in Clinical Drug Research - HIV
View Sample

Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - HIV

Volume 1
eBook: US $100 Special Offer (PDF + Printed Copy): US $191
Printed Copy: US $141
Library License: US $400
ISSN: 2468-0397 (Print)
ISSN: 2352-5916 (Online)
ISBN: 978-1-60805-897-6 (Print)
ISBN: 978-1-60805-896-9 (Online)
Year of Publication: 2015
DOI: 10.2174/97816080589691140101
Rate This Book

Introduction

Frontiers in Clinical Drug Research – HIV is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of acquired immune deficiency syndrome (AIDS) and other disorders associated with human immunodeficiency virus (HIV) infection. The scope of the eBook series covers a range of topics including the medicinal chemistry and pharmacology of natural and synthetic drugs employed in the treatment of AIDS (including HAART) and resulting complications, and the virology and immunological study of HIV and related viruses. Frontiers in Clinical Drug Research – HIV is a valuable resource for pharmaceutical scientists, clinicians and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in HIV/AIDS research.

The first volume of this series features 7 chapters that cover a variety of topics including:

  • - Antiretroviral drug development
  • - HIV-1 genomics
  • - HIV drug targets such as ribosomes and HIV Integrase
  • - HAART associated nephrotoxicity

Indexed in: Scopus, EMBASE, EBSCO.


eBook: US $100 Special Offer: US $191 Printed Copy: US $141 Library License: US $400

Contributors

Editor(s):
Atta-ur-Rahman
Kings College
University of Cambridge
Cambridge
UK



Contributor(s):
Benjamin L. Miller
Departement of Biochemistry and Biophysics, and Dermatology,
University of Rochester
Rochester
New York, 14642
USA


Elijah Paintsil
Department of Pediatrics
School of Medicine, Yale University
New Haven
CT 06520
USA


Hiroki Kumamoto
School of Pharmacy
Showa University
Tokyo 142-8555
Japan


Hiromichi Tanaka
School of Pharmacy
Showa University
Tokyo 142-8555
Japan


Jenny Svärd
Department of Medicine Huddinge
Karolinska Institutet
Unit of Infectious Diseases
Stockholm
Sweden


Johanie Charbonneau
Department of Biochemistry
University of Montreal
Montreal
Quebec
Canada H3T 1J4


Jorge Casseb
Department of Dermatology School of Medicine at University of Sao Paulo
Laboratory of Investigation in Dermatology and Immunodeficiencies – LIM56
Sao Paulo
Brazil


Kazuhiro Haraguchi
Department of Pharmaceutical Sciences
Nihon Pharmaceutical University
Saitama 362-0806
Japan


Kira Astakhova
Department of Physics, Chemistry and Pharmacy
Nucleic Acid Center
Campusvej 55
5230 Odense M
Denmark


Léa Brakier-Gingras
Department of Biochemistry
University of Montreal
Montreal
Quebec
Canada H3T 1J4


Liã Bárbara Arruda
Institute of Tropical Medicine of Sao Paulo
University of Sao Paulo
Sao Paulo
Brazil


Mark Ashton
Department of Pharmacy, Health and Wellbeing
University of Sunderland
Sunderland
Tyne and Wear
UK


Masanori Baba
Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases
Graduate School of Medical and Dental Sciences
Kagoshima University
Kagoshima 890-8544
Japan


Matthew Phillips
Department of Sexual and Reproductive Healthcare
Royal Bolton Hospital
Bolton
UK


Naheed Ansari
Division of Nephrology, Department of Medicine, Jacobi Medical Center
Albert Einstein College of Medicine
Bronx New York 10461
USA


Parikshit T. Hameer
Division of Nephrology, Department of Medicine, Jacobi Medical Center
Albert Einstein College of Medicine
Bronx New York 10461
USA


Shingo Takeda
School of Pharmacy
Showa University
Tokyo 142-8555
Japan


Siddhartha Yedla
Division of Nephrology, Department of Medicine, Jacobi Medical Center
Albert Einstein College of Medicine
Bronx New York 10461
USA


Takayuki Hamasaki
Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases
Graduate School of Medical and Dental Sciences
Kagoshima University
Kagoshima 890-8544
Japan


Victoria Hann
Department of Pharmacy, Health and Wellbeing
University of Sunderland
Sunderland
Tyne and Wear
UK


Yasuo Urata6
Oncolys BioPharma Inc.
4-1-28 Toranomon, Minato-ku
Tokyo 105-0001
Japan


Yung-Chi Cheng
Department of Pharmacology
School of Medicine, Yale University
New Haven
CT 06520
USA


Yutaka Kubota
School of Pharmacy
Showa University
Tokyo 142-8555
Japan



RELATED BOOKS

.COVID 19 – Monitoring with IoT Devices.
.Recent Advances in the Application of Marine Natural Products as Antimicrobial Agents.
.Recent Trends and The Future of Antimicrobial Agents - Part 2.
.COVID-19: Origin, Impact and Management (Part 1).